Offer - Urjas Oil for just ₹ 1
Esofence 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Esofence 40 Tablet is used -
Moderate
Mild
Is the use of Esofence 40 Tablet safe for pregnant women?
Esofence may have some side effects during pregnancy. Pregnant women should discontinue the use of Esofence, and talk to their doctor, if they notice any discomfort.
Is the use of Esofence 40 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Esofence. It should only be taken after medical advice.
What is the effect of Esofence 40 Tablet on the Kidneys?
Esofence does not damage the kidneys.
What is the effect of Esofence 40 Tablet on the Liver?
Very few cases of side effects of Esofence on the liver have been reported.
What is the effect of Esofence 40 Tablet on the Heart?
You can take Esofence without any fear of damage to the heart.
Esofence 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esofence 40 Tablet unless your doctor advises you to do so -
Is this Esofence 40 Tablet habit forming or addictive?
Forming a habit of Esofence 40 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Esofence 40 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, the use of Esofence 40 Tablet is considered safe.
Is it able to treat mental disorders?
No, Esofence 40 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Esofence 40 Tablet
Taking Esofence 40 Tablet with food does not cause any problems.
Interaction between Alcohol and Esofence 40 Tablet
Taking Esofence 40 Tablet with alcohol can have severely harmful effects on your health.
Yes, Esofence can be taken with Zantac. Both medicines work by reducing the acid secretion in the stomach which relieve from the stomach ulcer and acidity. No harmful drug interactions have been reported between them. Please consult your doctor before taking the two medications together.
Esofence works by blocking the action of an enzyme (H+/K+ATPase) in the cells (parietal) of the stomach which is responsible for acid production in the stomach. Due to blockage of this enzyme, the production of acid is decreased, and this helps to relieve the stomach from acidity, heartburn, GERD, stomach ulcer and other acidity related stomach problem.
Take Esofence as long as needed, but do not take more than 4 weeks. If your symptoms still persist even after 4 weeks then consult your doctor before taking this drug afterward.
Discontinuation of Esofence on your own can cause rebound effects. So, it advisable to take this drug as directed by the doctor and do not discontinue/stop medicine on your own. Please inform the doctor before stopping/discontinuing this drug on your own.
Yes, Esofence can be taken with sucralfate, take it at least 30 minutes before consuming sucralfate. If you experience any unwanted side effects after taking this two medicine at the same time then inform the doctor immediately and follow his/her instructions.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nexium (esomeprazole magnesium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 524-526